Related content

Differences in the Growth Pattern and Clinical Course of EBV-LMP1 Expressing and Non-expressing Nasopharyngeal Carcinomas

By Li-Fu H.   Fu C.   Qin-Fang Z.   You-Wang Z.   Yan L.   Xi Z.   Winberg G.   Ernberg I.   Klein G.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 658-660

Elsevier

Access to resources Recommend Favorite

Fisetin inhibits migration, invasion and epithelial-mesenchymal transition of LMP1-positive nasopharyngeal carcinoma cells

By Li Rong   Zhao Yinhai   Chen Jin   Shao Songjun   Zhang Xiujuan  

Molecular Medicine Reports, Vol. 9, Iss. 2, 2014-02 ,pp. : 413-418

Spandidos Publications

Access to resources Recommend Favorite

The significance of LMP1 expression in nasopharyngeal carcinoma

By Tsao S.W.   Tramoutanis G.   Dawson C.W.   Lo A.K.F.   Huang D.P.  

Seminars in Cancer Biology, Vol. 12, Iss. 6, 2002-12 ,pp. : 473-487

Academic Press

Access to resources Recommend Favorite

Role of LMP1 in immune control of EBV infection

By Pai S.   Khanna R.  

Seminars in Cancer Biology, Vol. 11, Iss. 6, 2001-12 ,pp. : 455-460

Academic Press

Access to resources Recommend Favorite

Role of the Epstein––Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma

By Morris Mhairi A   Dawson Christopher W   Young Lawrence S  

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 811-825

Future Medicine

Access to resources Recommend Favorite